Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 19141779)

1.

Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Kumar A, Kharfan-Dabaja MA, Glasmacher A, Djulbegovic B.

J Natl Cancer Inst. 2009 Jan 21;101(2):100-6. doi: 10.1093/jnci/djn439. Epub 2009 Jan 13. Review.

2.

Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review.

Mhaskar R, Kumar A, Behera M, Kharfan-Dabaja MA, Djulbegovic B.

Biol Blood Marrow Transplant. 2009 Aug;15(8):893-902. doi: 10.1016/j.bbmt.2009.01.022. Epub 2009 Apr 2. Review.

3.

High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.

Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC, Richardson PG, Anderson KC, Soiffer RJ, Alyea EP 3rd.

Biol Blood Marrow Transplant. 2007 Feb;13(2):183-96. Review.

4.

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies.

Naumann-Winter F, Greb A, Borchmann P, Bohlius J, Engert A, Schnell R.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD004626. doi: 10.1002/14651858.CD004626.pub3. Review.

PMID:
23076906
5.

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Mehta J.

J Natl Cancer Inst. 2009 Oct 21;101(20):1430-1; author reply 1431-3. doi: 10.1093/jnci/djp320. Epub 2009 Sep 30. No abstract available.

6.

Strategies to improve the outcome of stem cell transplantation in multiple myeloma.

Catley L, Anderson K.

Hematol J. 2004;5(1):9-23. Review.

PMID:
14745425
7.

High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis.

Greb A, Bohlius J, Trelle S, Schiefer D, De Souza CA, Gisselbrecht C, Intragumtornchai T, Kaiser U, Kluin-Nelemans HC, Martelli M, Milpied NJ, Santini G, Verdonck LF, Vitolo U, Schwarzer G, Engert A.

Cancer Treat Rev. 2007 Jun;33(4):338-46. Epub 2007 Apr 2.

PMID:
17400393
8.

Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Tricot G, Kern SE, Barlogie B.

J Natl Cancer Inst. 2009 Jul 1;101(13):964-6; author reply 966-7. doi: 10.1093/jnci/djp127. Epub 2009 Jun 17. No abstract available.

9.

Treatment of patients with multiple myeloma: an overview of systematic reviews.

Kumar A, Galeb S, Djulbegovic B.

Acta Haematol. 2011;125(1-2):8-22. doi: 10.1159/000318880. Epub 2010 Dec 8. Review.

10.
11.

Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea phase II trial.

Lahuerta JJ, Grande C, Martínez-Lopez J, De La Serna J, Toscano R, Ortiz MC, Larregla S, Conde E, Insunza A, Gonzalez-San Miguel JD, Bargay J, Cabrera R, García-Ruiz JC, Albó C, García-Alonso L, Solano F, Vivancos P, León A, San Miguel J; Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea.

Br J Haematol. 2003 Jan;120(2):296-303.

PMID:
12542490
12.

A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97.

Vesole DH, Zhang L, Flomenberg N, Greipp PR, Lazarus HM, Huff CA; ECOG Myeloma and BMT Committees.

Biol Blood Marrow Transplant. 2009 Jan;15(1):83-91. doi: 10.1016/j.bbmt.2008.10.030. Erratum in: Biol Blood Marrow Transplant. 2009 Oct;15(10):1346. Huff, Carol A [added].

13.

Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O.

J Natl Cancer Inst. 2009 Feb 18;101(4):248-55. doi: 10.1093/jnci/djn478. Epub 2009 Feb 10. Review.

14.

Results of high-dose treatment with autologous stem cell support in patients with multiple myeloma.

Fassas A, Tricot G.

Semin Hematol. 2001 Jul;38(3):231-42. Review.

PMID:
11486311
15.
16.

Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.

Cheema PK, Zadeh S, Kukreti V, Reece D, Chen C, Trudel S, Mikhael J.

Biol Blood Marrow Transplant. 2009 Jun;15(6):686-93. doi: 10.1016/j.bbmt.2009.02.013. Epub 2009 Apr 9.

17.

[Hemopoietic stem cell transplantation for multiple myeloma-review].

Chen WM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Aug;12(4):546-52. Review. Chinese.

PMID:
15363153
18.

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis.

Schulz H, Bohlius JF, Trelle S, Skoetz N, Reiser M, Kober T, Schwarzer G, Herold M, Dreyling M, Hallek M, Engert A.

J Natl Cancer Inst. 2007 May 2;99(9):706-14.

19.

A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma.

Hicks LK, Haynes AE, Reece DE, Walker IR, Herst JA, Meyer RM, Imrie K; Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care.

Cancer Treat Rev. 2008 Aug;34(5):442-52. doi: 10.1016/j.ctrv.2008.02.003. Epub 2008 Apr 1. Review.

PMID:
18381234
20.

Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.

Kim JS, Kim K, Cheong JW, Min YH, Suh C, Kim H, Jo DY, Ryoo HM, Yoon SS, Lee JH; Korean Multiple Myeloma Working Party.

Biol Blood Marrow Transplant. 2009 Apr;15(4):463-70. doi: 10.1016/j.bbmt.2008.12.512.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk